CC Quote, Financials, Valuation and Earnings

DuPont de Nemours has a net margin of -1.8% compared to The Chemours's net margin of 14.22%. The Chemours's return on equity of 10.59% beat DuPont de Nemours's return on equity of 3.28%.

The Chemours has a consensus price target of $23.44, signalling upside risk potential of 22.81%. On the other hand DuPont de Nemours has an analysts' consensus of $95.38 which suggests that it could grow by 24.41%. Given that DuPont de Nemours has higher upside potential than The Chemours, analysts believe DuPont de Nemours is more attractive than The Chemours.

The Chemours has a beta of 1.828, which suggesting that the stock is 82.775% more volatile than S&P 500. In comparison DuPont de Nemours has a beta of 1.354, suggesting its more volatile than the S&P 500 by 35.385%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 5.24%. DuPont de Nemours offers a yield of 1.98% to investors and pays a quarterly dividend of $0.38 per share. The Chemours pays -62.61% of its earnings as a dividend. DuPont de Nemours pays out 153.9% of its earnings as a dividend.

The Chemours quarterly revenues are $1.5B, which are smaller than DuPont de Nemours quarterly revenues of $3.2B. The Chemours's net income of -$27M is lower than DuPont de Nemours's net income of $454M. Notably, The Chemours's price-to-earnings ratio is 38.96x while DuPont de Nemours's PE ratio is 40.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.50x versus 2.66x for DuPont de Nemours. Usually stocks with elevated PS ratios are considered overvalued.

Huntsman has a net margin of -1.8% compared to The Chemours's net margin of -2.14%. The Chemours's return on equity of 10.59% beat Huntsman's return on equity of -3.46%.

The Chemours has a consensus price target of $23.44, signalling upside risk potential of 22.81%. On the other hand Huntsman has an analysts' consensus of $21.23 which suggests that it could grow by 21.95%. Given that The Chemours has higher upside potential than Huntsman, analysts believe The Chemours is more attractive than Huntsman.

The Chemours has a beta of 1.828, which suggesting that the stock is 82.775% more volatile than S&P 500. In comparison Huntsman has a beta of 0.974, suggesting its less volatile than the S&P 500 by 2.613%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 5.24%. Huntsman offers a yield of 5.74% to investors and pays a quarterly dividend of $0.25 per share. The Chemours pays -62.61% of its earnings as a dividend. Huntsman pays out 167.33% of its earnings as a dividend.

The Chemours quarterly revenues are $1.5B, which are smaller than Huntsman quarterly revenues of $1.5B. The Chemours's net income of -$27M is higher than Huntsman's net income of -$33M. Notably, The Chemours's price-to-earnings ratio is 38.96x while Huntsman's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.50x versus 0.50x for Huntsman. Usually stocks with elevated PS ratios are considered overvalued.

Koppers Holdings has a net margin of -1.8% compared to The Chemours's net margin of 4.11%. The Chemours's return on equity of 10.59% beat Koppers Holdings's return on equity of 14.89%.

The Chemours has a consensus price target of $23.44, signalling upside risk potential of 22.81%. On the other hand Koppers Holdings has an analysts' consensus of -- which suggests that it could grow by 102.7%. Given that Koppers Holdings has higher upside potential than The Chemours, analysts believe Koppers Holdings is more attractive than The Chemours.

The Chemours has a beta of 1.828, which suggesting that the stock is 82.775% more volatile than S&P 500. In comparison Koppers Holdings has a beta of 1.858, suggesting its more volatile than the S&P 500 by 85.813%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 5.24%. Koppers Holdings offers a yield of 0.88% to investors and pays a quarterly dividend of $0.07 per share. The Chemours pays -62.61% of its earnings as a dividend. Koppers Holdings pays out 5.61% of its earnings as a dividend. Koppers Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Chemours quarterly revenues are $1.5B, which are larger than Koppers Holdings quarterly revenues of $554.3M. The Chemours's net income of -$27M is lower than Koppers Holdings's net income of $22.8M. Notably, The Chemours's price-to-earnings ratio is 38.96x while Koppers Holdings's PE ratio is 9.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.50x versus 0.32x for Koppers Holdings. Usually stocks with elevated PS ratios are considered overvalued.

The Mosaic has a net margin of -1.8% compared to The Chemours's net margin of 4.35%. The Chemours's return on equity of 10.59% beat The Mosaic's return on equity of 3.06%.

The Chemours has a consensus price target of $23.44, signalling upside risk potential of 22.81%. On the other hand The Mosaic has an analysts' consensus of $32.30 which suggests that it could grow by 20.87%. Given that The Chemours has higher upside potential than The Mosaic, analysts believe The Chemours is more attractive than The Mosaic.

The Chemours has a beta of 1.828, which suggesting that the stock is 82.775% more volatile than S&P 500. In comparison The Mosaic has a beta of 1.338, suggesting its more volatile than the S&P 500 by 33.838%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 5.24%. The Mosaic offers a yield of 3.14% to investors and pays a quarterly dividend of $0.21 per share. The Chemours pays -62.61% of its earnings as a dividend. The Mosaic pays out 30.18% of its earnings as a dividend. The Mosaic's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Chemours quarterly revenues are $1.5B, which are smaller than The Mosaic quarterly revenues of $2.8B. The Chemours's net income of -$27M is lower than The Mosaic's net income of $122.2M. Notably, The Chemours's price-to-earnings ratio is 38.96x while The Mosaic's PE ratio is 23.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.50x versus 0.75x for The Mosaic. Usually stocks with elevated PS ratios are considered overvalued.